Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are affecting the digestive tract. The Company’s products include XIFAXAN, MOVIPREP, OSMOPREP, VISICOL, APRISO, METOZOLV, AZASAN, ANUSOL-HC, PROCTOCORT cream, PEPCID, Oral Suspension DIURIL and COLAZAL. The Company’s products under development include Rifaximin, Crofelemer, Balsalazide disodium tablet and Budesonide foam.
http://finance.yahoo.com/q?s=slxp&ql=1
http://www.google.com/finance?q=slxp
Target Price
Mean estimate : 51.47
Median estimate : 52.00
High estimate : 60.00
Low estimate : 37.00
High Preisziel vor einem Jahr war 40$. Aktuell handelt die Aktie über 40$ und die Analysten haben die Preisziele angepasst.